Bachem
Bachem is a leading, innovation-driven company
Company Bio
Specialised in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.
WuXi TIDES
Your End-to-End Partner for Oligonucleotide and Peptide Therapeutics
Company Bio
WuXi TIDES, a unique Contract Research and Development Manufacturing Organization (CRDMO) platform, is an integral part of WuXi AppTec. WuXi TIDES offers our worldwide partners efficient, flexible, and high-quality solutions for the drug development of oligonucleotides, peptides and related synthetic conjugates (“TIDES” drugs). We greatly simplify the TIDES drug development by providing all discovery, CMC development and the entire manufacturing supply chain under one roof.
CPC Scientific
Your Reliable CDMO Partner for GMP Peptide Manufacturing
Company Bio
We are a full-service peptide-focused CRDMO with vertically integrated capabilities in peptide drug development and manufacturing. Given the increasing complexity of new peptide drugs, which makes the development and manufacturing of peptides a time- and capital-intensive process, our tailored services are ideally suited for pharmaceutical and biotechnology companies seeking outsourcing solutions for their development and manufacturing needs.
PolyPeptide
Delivering Excellence in Peptide CDMO Solutions
Company Bio
PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a specialized Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world. PolyPeptide serves a fast-growing market, offering products and services from pre-clinical through to commercial stages. Its broad portfolio reflects the opportunities in drug therapies across areas and with a large exposure to metabolic diseases, including GLP-1. Dating back to 1952, PolyPeptide today runs a global network of six GMP-certified facilities in Europe, the U.S. and India. PolyPeptide’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.
Gyros Protein Technologies
Gyros Protein Technologies Precision Tools for Peptide Innovation
Company Bio
AmbioPharm, Inc.
AmbioPharm, Inc. – Your Trusted Partner in Peptide Manufacturing
Company Bio
AmbioPharm, a global peptide CDMO, was founded in 2005 and is headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient peptide manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at small to very large scales. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) and peptide APIs under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA with excellent outcomes.
Amide Technologies
Amide Technologies – Innovative Peptide Synthesis, Delivered
Company Bio
Sinopep
Sinopep – Your Partner in Peptide Innovation
Company Bio
At Sinopep, we are committed to advancing the frontiers of peptides, oligonucleotides, and small molecules as transformative therapeutic solutions. As a leader in pharmaceutical research, development, and manufacturing, we aim to set new standards across the industry. Our relentless focus on innovation, operational excellence, and scalable manufacturing has positioned us at the forefront of the global pharmaceutical landscape—delivering life-saving solutions and driving progress for our partners worldwide.
Intavis Peptide Services
Intavis Peptide Services – Reliable Peptide Solutions, Tailored for You
Company Bio
Acrotein
AnaSpec – Peptide and Assay Solutions for Life Science Innovation
Company Bio
Acrotein Chembio Inc. is headquartered in AL, USA. We are serving the customers worldwide with over 8000+ compounds in stock. Besides catalog products, our services include custom synthesis of novel building blocks, reference standard compounds, and bioactive compounds & natural Products, bulk manufacturing, sourcing and procurement.
University of Iowa Pharmaceuticals
Almac Group – Integrated Solutions from Discovery to Commercialization
Company Bio
Unified Separations Technologies
Innovative Solutions for Peptide Purification
Company Bio
Almac Group
Almac has supplied peptides to the research community and for clinical trials >20 years.
Company Bio
We have developed a high level of technical expertise, allowing us to manufacture peptides with a wide range of complexity.
Our service offering includes:
• High-throughput manufacture of peptides for pre-clinical research up to g scale
• Process development from research to GMP manufacture
• GMP-certified manufacture facility for scales from g to kg
• Experience in the manufacture of long peptides (>100 amino acids)
• Significant experience in conjugation of peptides to small molecule therapeutics, entities for half-life extension, and proteins
• Significant experience in the manufacture of peptide cocktails for vaccine product
• Expert knowledge for radiodiagnostic and radiotherapeutic programs
• Expert in-house analytical resource for method development, validation, release testing, and ICH stability studies.
Our technical expertise, coupled with our approach to customer care and project management, make Almac an excellent partner for peptide manufacture. Think Almac for peptide excellence.
Our service offering includes:
• High-throughput manufacture of peptides for pre-clinical research up to g scale
• Process development from research to GMP manufacture
• GMP-certified manufacture facility for scales from g to kg
• Experience in the manufacture of long peptides (>100 amino acids)
• Significant experience in conjugation of peptides to small molecule therapeutics, entities for half-life extension, and proteins
• Significant experience in the manufacture of peptide cocktails for vaccine product
• Expert knowledge for radiodiagnostic and radiotherapeutic programs
• Expert in-house analytical resource for method development, validation, release testing, and ICH stability studies.
Our technical expertise, coupled with our approach to customer care and project management, make Almac an excellent partner for peptide manufacture. Think Almac for peptide excellence.
Jiuzhou Pharma
Serve Life, Guard Health – we are committed to being a distinguished global life science company.
Company Bio
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (Abbreviated Name: Jiuzhou Pharma, Stock Code: 603456.SH), founded in 1998 and headquartered in Taizhou, Zhejiang, is a leading contract development and manufacturing organization (CDMO) of small molecules and peptide APIs that successfully evolved from a generic API manufacturer. We provide pharmaceutical companies worldwide with one-stop innovative drug development and manufacturing solutions and services throughout the development lifecycle of an innovative drug—from preclinical chemical manufacturing and control (CMC) through phase I/II/III clinical trials and new drug applications (NDA) to commercialization. As a leader in green pharmaceutical manufacturing, we have developed frontier environmentally friendly pharmaceutical technologies with independent intellectual property rights. We are committed to providing our customers with industry-leading technical solutions that enhance R&D efficiency and success while reducing costs. Serve Life, Guard Health – we are committed to being a distinguished global life science company that provides innovative drug solutions to help our partners accelerate the time to market of innovative drugs and benefit patients worldwide.
